Omar Ishrak’s SPAC Buys Allurion To Support Weight-Loss System

Allurion markets the Allurion Program, a unique temporary gastric balloon treatment paired with a digital health platform to support weight loss. Supported by $70m in new money from a merger with Compute Health Acquisition Corporation, the company hopes to submit a PMA to the FDA for system later this year.

Obesity Allurion's Balloon
• Source: Allurion Technologies

Allurion Technologies is taking a big step toward global commercialization of its unique weight-loss program by going public through a combination with Compute Health Acquisition Corporation.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Financing

More from Business